New Delhi: India has not received the Coronavirus vaccine from the US under its global donation program because certain regulatory issues raise inventories, people who are familiar with these developments on Wednesday.
Last month, the US promised to send 80 million doses of Covid-19 American vaccine to countries around the world to help them fight a pandemic.
A large number of countries, including in the Indian environment, have received vaccines from the US.
It is estimated that India can get one to two million doses of vaccines.
The people quoted above said the problem of compensation was related to the supply of US vaccines to India and the reason for delays.
Compensation grants will provide protection of vaccine suppliers from legal obligations in the event of a detrimental reaction between vaccine recipients.
When asked what to hold back the vaccine supply to India, a spokesman for the US Embassy said the delay was not from the US side.
“As President Joe Biden announced earlier this year, the United States will share 80 million doses of our own vaccine supply with countries around the world,” said the spokesman.
“As part of it, before we can send a dose, each country must complete the operational process, regulations, and its own domestic law specifically for each country,” said the spokesman.
Some countries in the region have received vaccine doses from the US as part of the donation.
“In the case of India: delays are not from the US side.
India has determined that it takes further time to review the legal provisions related to receiving vaccine contributions.
After India works through its legal process, our vaccine donation will continue quickly,” said the spokesman.
Minister of External Minister S Jaishankar visited the US in May where he had met the leading senior US pharmaceutical companies.
The supply of raw materials by the US to India to increase domestic production is the main focus of Jaisankar’s five-day visit to the US.
In early June, the US announced allocating 25 million first coronavirus vaccines to various countries.
It is said at least 75 percent of the total doses or nearly 19 million will be distributed through Covax, including around six million doses for Latin America and the Caribbean, and around seven million for South and Southeast Asia.
It is said that around five million will be sent to Africa and the remaining six million will be shared directly with countries that experience a surge and other partners and other neighbors, including Canada, Mexico, India and the Republic of Korea.
On June 23, the US came out with a planned allocation of 55 million doses.
Announced around 41 million will be distributed through Covax.
Of the 41 million doses, the US said around 14 million was for Latin America and the Caribbean countries while around 16 million doses would go to India, Nepal, Bangladesh, Pakistan, Sri Lanka, Afghanistan, Maldives, Bhutan, Philippines, Vietnam, Indonesia, Thailand, Malaysia, Laos, Papua New Guinea, Taiwan, Cambodia, and the Pacific Islands.
It is said that around 10 million doses will be shared with Africa.
14 million remaining – or 25 percent of 55 million vaccines will be distributed based on regional priorities and other recipients such as Colombia, Argentina, Haiti, Dominican Republic, Costa Rica, Panama, Afghanistan, Bangladesh, Vietnam, Philippines, Vietnam, Indonesia, South Africa, Nigeria, Kenya, Ghana, Cabo Verde and Egypt, among others.
US Vaccine Donation: Regulatory Problems holding Supplies to India
